WASHINGTON (AP) -- Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. That's raising insurance costs for all beneficiaries, whether or not they have the liver-wasting viral disease. The price of drugs is the public's top health care concern in opinion polls, and the 2016 presidential candidates are increasingly paying attention. The federal Department of Health and Human Services will hold a public forum next week to examine the high cost of new drugs...
↧